Once active, mTORC1 stimulates its downstream effector proteins, S6 and 4E-BP, which, respectively, increase ribosome biogenesis and mRNA translation.22 Activation of mTOR boosts overall cell growth and metabolism, making it a well-known target for cancer therapy. The gene discussed is MTOR; the disease is cancer.